Want to track VTVT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
vTv Therapeutics Inc. (VTVT) Statistics
Valuation metrics
Market Cap 84.12M
Enterprise value -13.97M
Trailing P/E (ttm) 120.22
Forward P/E -9.4
PEG ratio 1.73
Price/Sales (ttm) 2.28
Price/Book (mrq) 3.01
Enterprise Value/Revenue -0.38
Enterprise Value/EBITDA 7.25
Overview
Shares outstanding 3.94M
Float 2.4M
Shares short 136.96K
% Held by insiders 0.39%
% Held by institutions 0.38%
Average volume (10 days) 34.42K
Average volume (90 days) 58.11K
Price summary
52-Week low 14
52-Week high 44
Beta 0.26
50-Day moving average 33.9
200-Day moving average 35.04
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:40
Last split Date 21 Nov 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.06%
Operating margin -0.08%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.04%
Income Statement
Revenue (ttm) 36.84M
Revenue per share (ttm) 4.37
Quarterly revenue growth (yoy) -
Gross profit (ttm) 12.83M
EBITDA -3.03M
Net income to common (ttm) 2.25M
Diluted EPS (ttm) 0.27
Quarterly earnings growth (yoy) -1%
Balance Sheet
Total cash (mrq) 98.09M
Total cash per share (mrq) 11.64
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 14.36%
Book value per share (mrq) 10.68
Cash Flow
Cash flow statement -10.41M
Levered free cash flow (LFCF) 5.28M
